182 related articles for article (PubMed ID: 1963411)
1. Azithromycin concentrations at the sites of pulmonary infection.
Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
Eur Respir J; 1990 Sep; 3(8):886-90. PubMed ID: 1963411
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
[TBL] [Abstract][Full Text] [Related]
4. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
[TBL] [Abstract][Full Text] [Related]
5. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Conte JE; Golden J; Duncan S; McKenna E; Lin E; Zurlinden E
Antimicrob Agents Chemother; 1996 Jul; 40(7):1617-22. PubMed ID: 8807050
[TBL] [Abstract][Full Text] [Related]
6. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
[TBL] [Abstract][Full Text] [Related]
7. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
Gotfried MH; Danziger LH; Rodvold KA
J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses.
Olsen KM; San Pedro G; Gann LP; Gubbins PO; Halinski DM; Campbell GD
Antimicrob Agents Chemother; 1996 Nov; 40(11):2582-5. PubMed ID: 8913469
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis.
Cazzola M; Matera MG; Tufano MA; Polverino M; Catalanotti P; Varanese L; Rossi F
Pulm Pharmacol; 1994 Dec; 7(6):377-81. PubMed ID: 7549225
[TBL] [Abstract][Full Text] [Related]
11. Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
Cook PJ; Andrews JM; Wise R; Honeybourne D
J Antimicrob Chemother; 1996 Feb; 37(2):331-9. PubMed ID: 8707743
[TBL] [Abstract][Full Text] [Related]
12. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
Togami K; Chono S; Morimoto K
Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
[TBL] [Abstract][Full Text] [Related]
13. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.
Rodvold KA; Gotfried MH; Danziger LH; Servi RJ
Antimicrob Agents Chemother; 1997 Jun; 41(6):1399-402. PubMed ID: 9174209
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.
Stamler DA; Edelstein MA; Edelstein PH
Antimicrob Agents Chemother; 1994 Feb; 38(2):217-22. PubMed ID: 8192446
[TBL] [Abstract][Full Text] [Related]
17. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.
Rodvold KA; Danziger LH; Gotfried MH
Antimicrob Agents Chemother; 2003 Aug; 47(8):2450-7. PubMed ID: 12878504
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of telithromycin using bronchoscopic microsampling after single and multiple oral doses.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Pulm Pharmacol Ther; 2007; 20(5):549-55. PubMed ID: 17127087
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages.
Hodge S; Hodge G; Brozyna S; Jersmann H; Holmes M; Reynolds PN
Eur Respir J; 2006 Sep; 28(3):486-95. PubMed ID: 16737992
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.
Patel KB; Xuan D; Tessier PR; Russomanno JH; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1996 Oct; 40(10):2375-9. PubMed ID: 8891147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
